Maker of OxyContin agrees to $270M settlement in Oklahoma
The maker of OxyContin and the company’s controlling family agreed Tuesday to pay a groundbreaking $270 million to Oklahoma to settle allegations they helped create […]
Read moreHome » Medications »
The maker of OxyContin and the company’s controlling family agreed Tuesday to pay a groundbreaking $270 million to Oklahoma to settle allegations they helped create […]
Read more(HealthDay)—The U.S. Food and Drug Administration on Tuesday approved a new generic version of the high blood pressure/heart failure drug valsartan, saying the move might […]
Read moreThe nation’s largest health insurer is expanding a program that passes rebates from drugmakers directly to the people that use their medications. Beginning next year, […]
Read moreMedication options can be limited for people with chronic kidney disease, which is why they often get prescribed opioids to help manage pain. But new […]
Read moreA nationwide cohort study of all children born in Denmark to Danish-born mothers between 1999 through 2010 concluded that the mumps, measles, and rubella (MMR) […]
Read moreEli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices. The drugmaker says it will […]
Read moreDrug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren’t as effective as they could be. Oncologists haven’t had the right […]
Read moreParkinson’s disease and Amyotrophic Lateral Sclerosis are the newest frontiers for open science drug discovery, a global movement led by academic scientists in Toronto that […]
Read moreMany new anti-cancer drugs inhibit proteins that are essential for the proliferation of cancer cells. One example is ibrutinib, an innovative therapy for chronic lymphocytic […]
Read moreHealth officials are looking into a possible link between prescription opioids and a horrific birth defect. When a baby is born with its intestines hanging […]
Read more